Deprescribing in Older People: A Clinical Practice Guideline Summary

Quek HW, Reus Perello X, Lee K, Abraham A, Adams LA, Almeida OP, Almutairi H, Armstrong B, Boase L, Breen J, Brown LJ, Caughey GE, Chan LW, Chen R, Chew E, Clark A, Comans T, Criddle D, Dārziņš P, Dawda P, Doust JA, Edwards S, Gowan J, Hart K, Hawthorne D, Heredia A, Hill AM, Jansen J, Kalisch Ellett L, Keen H, Kelty EA, Kerse NM, Kruger E, Kurrle SE, Lance H, Livori A, Livori R, LoGiudice DC, Mangoni AA, Marinucci A, McKay N, Mckendrick AM, McLachlan AJ, McGuire TM, Mearns S, Morgan M, Nabi S, Naganathan V, Newman E, Ng CACM, Osborne M, Parkin R, Polkinghorne KR, Pond CD, Potter K, Rigby D, Rowett D, Schipp A, Seda V, Seeto J, Shakib S, Shiu A, Stafford AC, Tan IJ, Tennant M, Teoh L, Tucker S, Watson JDG, Wellins D, Whitmore T, Etherton-Beer C, Page AT.

https://onlinelibrary.wiley.com/doi/10.5694/mja2.70174

Previous
Previous

Change in prescription opioid dose and the risk of mental health-related and substance use-related emergency department presentations: a case-crossover study

Next
Next

Living evidence syntheses for long COVID therapeutics: combining rigorous protocols to build efficiency while maintaining rigour